Market revenue in 2023 | USD 187.9 million |
Market revenue in 2030 | USD 442.8 million |
Growth rate | 13% (CAGR from 2023 to 2030) |
Largest segment | Bioreactors/fermenters |
Fastest growing segment | Cell Culture Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 33.26% in 2023. Horizon Databook has segmented the South Africa upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa is undertaking various initiatives, especially in vaccine development. Upstream bioprocessing is one of the essential steps in vaccine development. Hence, these initiatives are expected to boost the upstream bioprocessing industry in the country.
It aimed to promote fair access to vaccines in Africa, aligning with the African Union's objective of elevating the share of vaccine supply from African manufacturers to 60% by 2040. The strategic alliance is expected to enhance the manufacturing capabilities of cost-effective vaccines at IPD's Dakar facilities.
Furthermore, it will establish a reserve capacity for producing vaccines for Global South countries during future outbreaks and pandemics, which is expected to drive the upstream bioprocessing market in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account